These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 10952326)

  • 41. Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation.
    Hutchinson K; Kopko PM; Muto KN; Tuscano J; O'Donnell RT; Holland PV; Richman C; Paglieroni TG; Wun T
    Transfusion; 2002 Dec; 42(12):1567-72. PubMed ID: 12473136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transfusion-associated graft-versus-host disease in an immunocompetent individual following cardiac surgery.
    Serefhanoglu K; Turan H; Saba T; Ozer I; Tosun E; Arslan H
    J Natl Med Assoc; 2005 Mar; 97(3):418-20. PubMed ID: 15779510
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transfusion-associated GVHD: 10 years' experience at the American University of Beirut-Medical Center.
    Aoun E; Shamseddine A; Chehal A; Obeid M; Taher A
    Transfusion; 2003 Dec; 43(12):1672-6. PubMed ID: 14641862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A systematic review of transfusion-associated graft-versus-host disease.
    Kopolovic I; Ostro J; Tsubota H; Lin Y; Cserti-Gazdewich CM; Messner HA; Keir AK; DenHollander N; Dzik WS; Callum J
    Blood; 2015 Jul; 126(3):406-14. PubMed ID: 25931584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fatal graft-versus-host disease following transfusion during open heart surgery.
    Aso T; Asano Y; Harada M; Kudo J; Fujimoto K; Okamura T; Tsuda Y; Niho Y
    Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1064-71. PubMed ID: 2588955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disseminated intravascular coagulation in transfusion-associated graft-versus-host disease. Report of two cases.
    Murakawa M; Okamura T; Harada M; Esaki T; Kamura T; Shibuya T; Niho Y
    Ann Clin Lab Sci; 1995; 25(1):31-8. PubMed ID: 7762966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: a retrospective analysis from the Japan Society for Hematopoietic Cell Transplantation.
    Kanda J; Ichinohe T; Fuji S; Maeda Y; Ohashi K; Fukuda T; Miyamura K; Iwato K; Eto T; Nakamae H; Kobayashi N; Mori T; Mori S; Morishima Y; Atsuta Y; Kanda Y;
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):305-11. PubMed ID: 25464119
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transfusion-associated graft-versus-host disease.
    Dwyre DM; Holland PV
    Vox Sang; 2008 Aug; 95(2):85-93. PubMed ID: 18544121
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of transfusion-associated graft-versus-host disease].
    Yasukawa M
    Nihon Rinsho; 1997 Sep; 55(9):2290-5. PubMed ID: 9301292
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transfusion-associated graft-versus-host disease: do transfusions from second-degree relatives pose a greater risk than those from first-degree relatives?
    Kanter MH
    Transfusion; 1992 May; 32(4):323-7. PubMed ID: 1585436
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transfusion-associated graft-versus-host disease reexamined: potential for improved prevention using a universally applied intervention.
    Kleinman S; Stassinopoulos A
    Transfusion; 2018 Nov; 58(11):2545-2563. PubMed ID: 30267423
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transfusion-associated graft versus host disease following hepatectomy for hepatocellular carcinoma--a case report.
    Kosuga K; Ohgami N; Okuda K; Kinoshita H; Taniwaki S; Hisatomi K; Shimada S; Nakayama T; Ohishi K
    Kurume Med J; 1993; 40(4):193-9. PubMed ID: 8007627
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Leukoreduction of blood transfusions does not diminish transfusion-associated microchimerism in trauma patients.
    Utter GH; Nathens AB; Lee TH; Reed WF; Owings JT; Nester TA; Busch MP
    Transfusion; 2006 Nov; 46(11):1863-9. PubMed ID: 17076839
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unmanipulated HLA-mismatched/haploidentical peripheral blood stem cell transplantation for high-risk hematologic malignancies.
    Huang W; Li H; Gao C; Bo J; Wang Q; Zhao Y; Jing Y; Wang S; Zhu H; Dou L; Wang L; Yu L
    Transfusion; 2012 Jun; 52(6):1354-62. PubMed ID: 22233440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of ABO incompatibility on outcome after allogeneic peripheral blood stem cell transplantation.
    Kim JG; Sohn SK; Kim DH; Baek JH; Lee KB; Min WS; Kim CC; Lee MH; Lee JJ; Chung IJ; Kim HJ; Lee JW
    Bone Marrow Transplant; 2005 Mar; 35(5):489-95. PubMed ID: 15654350
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transfusion-associated graft-versus-host disease in an immunocompetent patient following cardiac surgery.
    Rososhansky S; Badonnel MC; Hiestand LL; Popovsky MA; Szymanski IO
    Vox Sang; 1999; 76(1):59-63. PubMed ID: 9933856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
    Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The effects of transfusion of irradiated blood upon cellular immune response in patients underwent open heart surgery].
    Togashi K; Nakazawa S; Moro H; Yazawa M; Kanazawa H; Hayashi J; Yamazaki Y; Eguchi S
    Nihon Kyobu Geka Gakkai Zasshi; 1989 Sep; 37(9):1958-64. PubMed ID: 2600470
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
    Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.